ACT

Analyst Note: Enact Holdings, Inc. (ACT)

Date: 2026-06-13 Current Price: $42.39

1. Structural Readiness

State: Context-Only Conservative Entry: — Breakout Level: — Extension: — ATR Current: 2.1% (Sub-threshold)

Analysis:

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Macro Thesis: None.

There is no named secular thesis attached to ACT as of this date. The investment case is strictly tactical and setup-led. We are not assigning a macro narrative (e.g., "housing recovery" or "rate cut beneficiary") to this name. The conviction must be derived entirely from the quality of the business fundamentals, the strength of the recent earnings execution, and the eventual formation of a technical setup. We judge this name on its operational metrics and capital allocation, not on an invented macro tailwind.

3. The Business

Company Profile: Enact Holdings, Inc. operates as a specialized provider of private mortgage insurance (PMI) across the United States. It is a subsidiary of Genworth Holdings, Inc. The company furnishes PMI offerings, predominantly safeguarding prime, individually assessed residential mortgage loans, and supplies contract underwriting services to various mortgage lenders. Its primary customers are originators of residential mortgage loans who determine which insurer to use for placement.

Operational Metrics (as of Q1 2026):

• New Insurance Written (NIW): The company generated $13 billion in new insurance written in Q1 2026, a 30% increase year-over-year compared to Q1 2025 ($12.8 billion reported in the 10-K context). Total Insurance in Force (IIF) stands at $272 billion.
• Profitability: Adjusted operating income for Q1 2026 was $172 million, or $1.21 per diluted share.
• Persistency: Persistency remained elevated at 80% in Q1 2026, down slightly from 84% in Q1 2025 but still supporting the portfolio.
• Portfolio Quality: The IIF portfolio maintains a risk-weighted average FICO score of 746 and a risk-weighted average Loan-to-Value (LTV) ratio of 93%. Layered risk is 1.2% of risk in force.
• Capital Sufficiency: PMIERs sufficiency was 162% ($1.9 billion above requirements) as of Q1 2026. A third-party CRT program provides an additional $1.9 billion of PMIERs capital credit.
• Guidance & Capital Return: Management anticipates operating expenses in the range of $215 million to $220 million for the full year 2026, excluding reorganization costs. Total capital return guidance remains unchanged at approximately $500 million for 2026.
• Dividend: In May 2026, management announced an increase in the quarterly dividend from $0.21 to $0.24 per common share, payable in June 2026.

Market Context: The U.S. private mortgage insurance industry is highly competitive. The GSEs held or guaranteed approximately $7.8 trillion (53% of total U.S. 1-4 family residential mortgage debt) as of September 30, 2025. The company's largest customer accounted for 22% of total NIW and 12% of total revenues in 2025.

4. Archetype and Conviction

Archetype: Quality Compounder Rationale: ACT fits the Quality Compounder archetype based on its consistent capital return profile, resilient portfolio metrics, and disciplined expense management.

• Margin Inflector/Capital Allocator: The company has demonstrated a clear commitment to returning capital to shareholders, with a $500 million guidance for 2026 and a recent dividend increase.
• Resilience: The portfolio quality (FICO 746, LTV 93%) and high persistency (80%) suggest a business model that withstands market cycles better than speculative peers.
• Valuation Context: The financial spine indicates a forward consensus EPS of $4.75 for FY1 and $5.00 for FY2. At a current price of $42.39, the stock trades at approximately 8.9x FY1 EPS and 8.5x FY2 EPS. This valuation implies a market expectation of steady, moderate growth rather than explosive expansion.

Conviction Stack:

• Thesis Strength: Low (Tactical only, no macro thesis).
• Evidence Quality: High. The earnings transcript and 10-K filings provide robust, point-in-time data on NIW growth, capital sufficiency, and portfolio quality.
• Structural Quality: Neutral. The setup is currently undefined (context-only).
• Setup Readiness: Low. No breakout or forming coil is present.
• Rerating Potential: Moderate. The combination of a dividend increase, strong NIW growth (30% YoY), and a clean balance sheet (162% PMIERs sufficiency) provides a fundamental floor, but the lack of a technical setup limits immediate rerating catalysts.

5. Invalidations, Strengtheners, and Gaps

Invalidation Triggers:

• Fundamental: A significant deterioration in persistency rates below 75% or a breach of the PMIERs capital sufficiency threshold (currently 162%) would invalidate the "Quality Compounder" thesis.
• Guidance: Management reducing the 2026 capital return guidance below $500 million or raising expense guidance significantly above $220 million would weaken the case.

Strengtheners:

• Fundamental: Continued NIW growth exceeding 30% YoY or an expansion of the dividend beyond the current $0.24 quarterly run rate.
• Portfolio: An increase in the risk-weighted average FICO score or a reduction in the LTV ratio, indicating further portfolio quality improvement.

Evidence Gaps:

• Macro Sensitivity: While the company mentions "lower rates early in the quarter supported elevated refinance applications," there is no specific data on how a sustained rate environment change would impact the 2026 NIW pipeline beyond the Q1 snapshot.
• Customer Concentration: While the largest customer is disclosed (22% of NIW), there is no granular data on the concentration risk of the top 5 customers in the current quarter.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Key evidence: Q1 2026 NIW grew 30% YoY to $13 billion; PMIERs sufficiency at 162% with $1.9B CRT credit; Dividend increased to $0.24/share in May 2026. Key risks: No defined technical setup (context-only state); Industry is highly competitive with significant customer concentration (22% from top customer); Persistency declined slightly to 80% from 84% YoY. Sizing hint: Position size should be minimal or zero until a structural breakout or forming coil is defined; current volatility (2.1% ATR) is sub-threshold for aggressive sizing. Expected path: Management expects to maintain $500M capital return and $215-220M operating expenses; portfolio quality remains resilient with FICO 746; technical structure must form before capital deployment. Expected horizon: 3-6 months for structural setup definition; 12 months for full-year capital return execution.